Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
AY.25.2 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.122.6 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.621.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.39.2 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.125 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.103.1 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.92 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.122.4 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.101 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.1.5NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.1.14NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.57NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.49NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BE.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.4.8NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.9.6NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.13NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.69NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.1.4.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BQ.1.17NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
CC.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BZ.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
CK.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BF.13NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
CM.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.5.1.4NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.5.1.34NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BQ.1.6NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.35NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
EG.1.5NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.8NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XAY.2.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
CH.1.1.8NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.5.2.36NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BV.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BF.26NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.5.1.33NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
CP.5NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.45NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BN.1.7NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BF.5.5NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.1.41NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.75.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.5.1.20NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
CR.1.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
DV.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BT.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BE.1.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XMNWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.1.1.4NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used